Prothrombin kringle-2 induces death of mesencephalic dopaminergic neurons in vivo and in vitro via microglial activation
Abstract
We have shown that prothrombin kringle-2 (pKr-2), a domain of human prothrombin distinct from thrombin could activate cultured rat brain microglia in vitro. However, little is known whether pKr-2-induced microglial activation could cause neurotoxicity on dopaminergic (DA) neurons in vivo. To address this question, pKr-2 was injected into the rat substantia nigra (SN). Tyrosine hydroxylase (TH) immunohistochemistry experiments demonstrate significant loss of DA neurons seven days after injection of pKr-2. In parallel, pKr-2-activated microglia were detected in the SN with OX-42 and OX-6 immunohistochemistry. Reverse transcription PCR and double-label immunohistochemistry revealed that activated microglia in vivo exhibit early and transient expression of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2) and several proinflammatory cytokines. The pKr-2-induced loss of SN DA neurons was partially inhibited by the NOS inhibitor N(G)-nitro-L-arginine methyl ester hydrochloride, and the COX-2 inhibitor DuP-697. Extracellular signal-regulated kinase 1/2, c-Jun N-terminal kinase and p38 mitogen-activated protein kinase were activated in the SN as early as 1 hr after pKr-2 injection, and localized within microglia. Inhibition of these kinases led to attenuation of mRNA expression of iNOS, COX-2 and several proinflammatory cytokines, and rescue of DA neurons in the SN. Intriguingly, following treatment with pKr-2 in vitro, neurotoxicity was detected exclusively in co-cultures of mesencephalic neurons and microglia, but not microglia-free neuron-enriched mesencephalic cultures, indicating that microglia are required for pKr-2 neurotoxicity. Our results strongly suggest that microglia activated by endogenous compound(s), such as pKr-2, are implicated in the DA neuronal cell death in the SN.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
pKr-2 induced DA neuronal death in an experimental PD model.
“Also, pKr-2 induced DA neuronal death in an experimental PD model (Kim et al., 2010).”
From The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma. (2017) · cites this paper as Kim et al., 2010
Cites
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110 · see citing works
West, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994 · see citing works
The coagulation cascade: initiation, maintenance, and regulation
Davie, E. W., Fujikawa, K., & Kisiel, W. (1991) · Biochemistry · doi:10.1021/bi00107a001 · Cited by 1,821 · see citing works
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183 · see citing works
Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046 · cited 2× · see citing works
“This finding is consistent with previous studies showing that nigral DA neurons in iNOS-deficient mice are protected against MPTP neurotoxicity (Liberatore et al., 1999), and LPSinduced NO production in microglia leads to DA neuronal death in the SN (Tian et al.”
ResultKim, W., Mohney, R. P., Wilson, B. C., Jeohn, G., Liu, B., & Hong, J. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06309.2000 · Cited by 881 · see citing works
Bhat, N. R., Zhang, P., Lee, J. C., & Hogan, E. L. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-05-01633.1998 · Cited by 714 · see citing works
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration
Teismann, P., Tieu, K., Choi, D., Wu, D., Naini, A., Hunot, S., Vila, M., Jackson-Lewis, V. R., & Przedborski, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0837397100 · Cited by 659 · see citing works
Qin, L., He, J., Hanes, R. N., Pluzarev, O., Hong, J.-S., & Crews, F. T. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-10 · Cited by 532 · see citing works
Oxidative stress and inflammation in Parkinson's disease: is there a causal link?
Hald, A., & Lotharius, J. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.01.013 · Cited by 506 · see citing works
Cicchetti, F., Brownell, A., Williams, K. S., Chen, Y. I., Livni, E., & Ole Isacson, A. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01938.x · Cited by 406 · see citing works
Ghoshal, A., Das, S., Ghosh, S. K., Mishra, M. K., Sharma, V., Koli, P., Sen, E., & Basu, A. (2007) · Glia · doi:10.1002/glia.20474 · Cited by 387 · see citing works
Prothrombin mRNA is expressed by cells of the nervous system
Dihanich, M., Kaser, M. R., Reinhard, E., Cunningham, D. D., & Monard, D. (1991) · Neuron · doi:10.1016/0896-6273(91)90060-d · Cited by 338 · see citing works
Hunter, R. L., Dragicevic, N., Seifert, K., Choi, D. Y., Liu, M., Kim, H., Cass, W. A., Sullivan, P. G., & Bing, G. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04327.x · Cited by 322 · see citing works
Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase
Brown, G. C. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351119 · Cited by 315 · see citing works
c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia
Waetzig, V., Czeloth, K., Hidding, U., Mielke, K., Kanzow, M., Brecht, S., Goetz, M. E., Lucius, R., Herdegen, T., & Hanisch, U. (2005) · Glia · doi:10.1002/glia.20173 · Cited by 291 · see citing works
Serine proteases and brain damage – is there a link?
Gingrich, M. B., & Traynelis, S. F. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01617-9 · Cited by 274 · see citing works
Rogers, J., Mastroeni, D., Leonard, B., Joyce, J., & Grover, A. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(07)82012-5 · Cited by 260 · see citing works
Microglial Activation and Matrix Protease Generation During Focal Cerebral Ischemia
del Zoppo, G. J., Milner, R., Mabuchi, T., Hung, S. Y., Wang, X., Berg, G. I., & Koziol, J. A. (2007) · Stroke · doi:10.1161/01.str.0000254477.34231.cb · Cited by 234 · see citing works
Weinstein, J. R., Gold, S., Cunningham, D., & Gall, C. M. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-04-02906.1995 · Cited by 226 · see citing works
Mann, K. G. (1976) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(76)45016-4 · Cited by 200 · see citing works
Fenton, J. W. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb34563.x · Cited by 189 · see citing works
Participation of protease‐activated receptor‐1 in thrombin‐induced microglial activation
Suo, Z., Wu, M., Ameenuddin, S., Anderson, H. E., Zoloty, J. E., Citron, B. A., Andrade‐Gordon, P., & Festoff, B. W. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00745.x · Cited by 176 · see citing works
Thrombin-Induced Microglial Activation Produces Degeneration of Nigral Dopaminergic NeuronsIn Vivo
Choi, S.-H., Joe, E. H., Kim, S. U., & Jin, B. K. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05877.2003 · Cited by 165 · see citing works
Self-citationKim, S. R., Lee, D. Y., Chung, E. S., Oh, U. T., Kim, S. U., & Jin, B. K. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4166-04.2005 · Cited by 155 · see citing works
Self-citationChoi, S., Lee, D. Y., Kim, S. U., & Jin, B. K. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4306-04.2005 · Cited by 155 · see citing works
Self-citationTian, Y.-Y., An, L., Jiang, L., Duan, Y.-L., Chen, J., & Jiang, B. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.09.010 · Cited by 133 · see citing works
Microglial activation in Alzheimer's disease.
Schlachetzki, J., & Hüll, M. H. (2009) · Current Alzheimer Research · doi:10.2174/156720509790147179 · Cited by 125 · see citing works
Agrin and microvascular damage in Alzheimer's disease.
Berzin, T., Zipser, B., Rafii, M., Kuo-Leblanc, V., Yancopouloš, G., Glass, D., Fallon, J., & Stopa, E. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00121-4 · Cited by 116 · see citing works
Soifer, S. J., Peters, K. G., O’Keeffe, J., & Coughlin, S. R. (1994) · PubMed Central · Cited by 114 · see citing works
Choi, S. H., Lee, D. Y., Chung, E. S., Hong, Y. B., Kim, S. U., & Jin, B. K. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03503.x · Cited by 111 · see citing works
Self-citationLiu, B. (2006) · The AAPS Journal · doi:10.1208/aapsj080369 · Cited by 100 · see citing works
Lee, T.-H., Rhim, T., & Kim, S. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.44.28805 · Cited by 95 · see citing works
Self-citationLee, D. Y., Oh, Y. J., & Jin, B. K. (2005) · Glia · doi:10.1002/glia.20190 · Cited by 88 · see citing works
Self-citationZhou, F., Wu, J., Sun, X., Yao, H., Ding, J., & Hu, G. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301381 · Cited by 85 · see citing works
Ryu, J. K., Nagai, A., Kim, J., Lee, M. C., McLarnon, J. G., & Kim, S. U. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00002-0 · Cited by 81 · see citing works
Self-citationChoi, S.-H., Lee, D. Y., Ryu, J. K., Kim, J., Joe, E. H., & Jin, B. K. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00085-8 · Cited by 65 · see citing works
Self-citationRyu, J. K., Shin, W. H., Kim, J., Joe, E. H., Lee, Y. B., Cho, K. G., Oh, Y. J., Kim, S. U., & Jin, B. K. (2002) · Glia · doi:10.1002/glia.10047 · Cited by 61 · see citing works
Self-citationDecreases in protease nexins in Alzheimer's disease brain
Choi, B.-T. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00060-r · Cited by 53 · see citing works
Rosales‐Corral, S. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.01.005 · Cited by 50 · see citing works
Human Prothrombin Fragment 1 and 2 Inhibit bFGF-Induced BCE Cell Growth
Rhim, T. Y., Park, C.-S., Kim, E., & Kim, S. S. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9682 · Cited by 44 · see citing works
Self-citationProthrombin Kringle-2 Activates Cultured Rat Brain Microglia
Ryu, J., Min, K., Rhim, T. Y., Kim, T. H., Pyo, H., Jin, B.-K., Kim, S.-U., Jou, I., Kim, S. S., & Joe, E.-H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5805 · Cited by 36 · see citing works
Self-citationBlood Coagulation Factor Xa Interacts with a Linear Sequence of the Kringle 2 Domain of Prothrombin
Taneda, H., Andoh, K., Nishioka, J., Takeya, H., & Suzuki, K. (1994) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a124565 · Cited by 36 · see citing works
Kim, T. H., Oh, S. V., & Kim, S. S. (2006) · Angiogenesis · doi:10.1007/s10456-005-9020-y · Cited by 16 · see citing works
Self-citationInhibition of thrombin activity by prothrombin activation fragment 1.2
Dasgupta, S. K., & Thiagarajan, P. (2007) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-007-0018-8 · Cited by 12 · see citing works
Kim, T. H., Ahn, S., Kim, J., Kim, I., Yang, M. Z., Lee, J. E., & Kim, S. S. (2006) · Clinical & Experimental Metastasis · doi:10.1007/s10585-006-9048-4 · Cited by 6 · see citing works
Self-citationHwang, H. S., Kim, D. W., & Kim, S. S. (2006) · Biochemical Journal · doi:10.1042/bj20051300 · Cited by 6 · see citing works
Self-citationHwang, H. S., & Kim, S. S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.090 · Cited by 4 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Leyane, T. S., Jere, S. W., & Houreld, N. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137273 · Cited by 510 · see citing works
The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma.
Ramirez, A. I., de Hoz, R., Salobrar-Garcia, E., Salazar, J. J., Rojas, B., Ajoy, D., López-Cuenca, I., Rojas, P., Triviño, A., & Ramírez, J. M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00214 · Cited by 466 · see citing works
The role of Toll-like receptors and neuroinflammation in Parkinson’s disease
Heidari, A., Yazdanpanah, N., & Rezaei, N. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02496-w · Cited by 275 · see citing works
The role of neuroinflammation on the pathogenesis of Parkinson's disease
Chung, Y. C., Ko, H. W., Bok, E., Park, E. S., Huh, S. H., Nam, J. H., & Jin, B. K. (2010) · BMB Reports · doi:10.5483/bmbrep.2010.43.4.225 · Cited by 148 · see citing works
Self-citationp38 MAPK and PI3K/AKT Signalling Cascades inParkinson's Disease.
Jha, S. K., Jha, N. K., Kar, R., Ambasta, R. K., & Kumar, P. (2015) · Europe PMC (PubMed Central) · Cited by 143 · see citing works
Kim, T. Y., Leem, E., Lee, J. M., & Kim, S. R. (2020) · Antioxidants · doi:10.3390/antiox9070583 · Cited by 128 · see citing works
Self-citationPathogenic Upregulation of Glial Lipocalin-2 in the Parkinsonian Dopaminergic System
Kim, B.-W., Jeong, K. H., Kim, J., Jin, M., Kim, J., Lee, M., Choi, D., Won, S.-Y., McLean, C., Jeon, M., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.4261-15.2016 · Cited by 118 · see citing works
Self-citationTranslocator Protein 18 kDa Negatively Regulates Inflammation in Microglia
Bae, K.-R., Shim, H.-J., Balu, D., Kim, S. R., & Yu, S. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9540-6 · Cited by 115 · see citing works
Self-citationHussain, G., Zhang, L., Rasul, A., Anwar, H., Sohail, M. U., Razzaq, A., Aziz, N., Shabbir, A., Ali, M. Z., & Sun, T. (2018) · Molecules · doi:10.3390/molecules23040814 · Cited by 106 · see citing works
Yang, W., Chen, Y., Liu, H., & Qu, H. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2356 · Cited by 105 · see citing works
Jeon, M.-T., Kim, K.-S., Kim, E. S., Lee, S., Kim, J., Hoe, H.-S., & Kim, D.-G. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101333 · Cited by 76 · see citing works
Kim, H. D., Jeong, K. H., Jung, U. J., & Kim, S. R. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.10.013 · Cited by 72 · see citing works
Self-citationShin, W.-H., Jeon, M., Leem, E., Won, S.-Y., Jeong, K. H., Park, S., McLean, C., Lee, S. J., Jin, B. K., Jung, U. J., et al. (2015) · Scientific Reports · doi:10.1038/srep14764 · Cited by 65 · see citing works
Self-citationJeong, K. H., Jeon, M., Kim, H. D., Jung, U. J., Jang, M. C., Chu, J. W., Yang, S. J., Choi, I. Y., Choi, M.-S., & Kim, S. R. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2014.3241 · Cited by 58 · see citing works
Self-citationSilymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms
Haddadi, R., Shahidi, Z., & Brooshghalan, S. E. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153320 · Cited by 55 · see citing works
Jang, H., Kim, S., Lee, J. M., Oh, Y., Park, S. M., & Kim, S. R. (2017) · Neuroreport · doi:10.1097/wnr.0000000000000740 · Cited by 48 · see citing works
Self-citationSilibinin Attenuates MPP + -Induced Neurotoxicity in the Substantia Nigra In Vivo
Jung, U. J., Jeon, M., Choi, M., & Kim, S. R. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2013.2926 · Cited by 47 · see citing works
Self-citationKim, H. D., Jeong, K. H., Jung, U. J., & Kim, S. R. (2016) · Journal of Medicinal Food · doi:10.1089/jmf.2015.3581 · Cited by 41 · see citing works
Self-citationBai, L., Zhang, X., Li, X., Liu, N., LOU, F., MA, H., Luo, X., & Ren, Y. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3494 · Cited by 41 · see citing works
Kim, S., Sharma, C., Jung, U. J., & Kim, S. R. (2023) · Biomedicines · doi:10.3390/biomedicines11051383 · Cited by 40 · see citing works
Self-citationAzrad, M., Zeineh, N., Weizman, A., Veenman, L., & Gavish, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030594 · Cited by 37 · see citing works
Jeong, J. Y., Chung, Y. C., & Jin, B. K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081927 · Cited by 37 · see citing works
Self-citationThe Role and Mechanisms of Action of Catechins in Neurodegenerative Diseases
Özduran, G., Becer, E., & Vatansever, H. S. (2021) · Journal of the American Nutrition Association · doi:10.1080/07315724.2021.1981487 · Cited by 32 · see citing works
Naringin: A Protector of the Nigrostriatal Dopaminergic Projection
Jung, U. J., Leem, E., & Kim, S. R. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.2.124 · Cited by 31 · see citing works
Self-citationWon, S.-Y., Kim, S. R., Maeng, S., & Jin, B. K. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.09.014 · Cited by 29 · see citing works
Self-citationEffects of Myricitrin and Relevant Molecular Mechanisms
Ma, R., Zhang, X., Zhang, K., & Wang, Y. (2018) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x14666181126103338 · Cited by 25 · see citing works
Proteolytically Derived Endogenous Angioinhibitors Originating from the Extracellular Matrix
Boosani, C. S., & Sudhakar, Y. A. (2011) · Pharmaceuticals · doi:10.3390/ph4121551 · Cited by 22 · see citing works
Thrombin A-Chain: Activation Remnant or Allosteric Effector?
Carter, I. S., Hoek, A. L. V., Pryzdial, E. L. G., & MacGillivray, R. T. A. (2010) · Thrombosis · doi:10.1155/2010/416167 · Cited by 18 · see citing works
Kim, S., Moon, G. J., Oh, Y., Park, J., Shin, W.-H., Jeong, J. Y., Choi, K. S., Jin, B. K., Kholodilov, N. G., Burke, R. E., et al. (2018) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.261 · Cited by 17 · see citing works
Self-citationProthrombin Kringle-2: a potential inflammatory pathogen in the parkinsonian dopaminergic system
Leem, E., Jeong, K. H., Won, S.-Y., Shin, W.-H., & Kim, S. R. (2016) · Experimental Neurobiology · doi:10.5607/en.2016.25.4.147 · Cited by 16 · see citing works
Self-citationKim, S., Moon, G. J., Kim, H. J., Kim, D., Kim, J., Nam, Y., Sharma, C., Leem, E., Lee, S., Kim, K., et al. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15681 · Cited by 14 · see citing works
Self-citationBhurtel, S., Bok, E., Katila, N., Kim, J., & Choi, D. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114719 · Cited by 14 · see citing works
Self-citationBrooshghalan, S. E., Sabahi, M., Ebadi, S. A., Sadeghian, Z., Nayebi, A. M., & Haddadi, R. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175517 · Cited by 13 · see citing works
Leem, E., Oh, Y., Shin, W.-H., Jin, B. K., Jeong, J. Y., Shin, M., Kim, D. W., Jang, J., Kim, H., Ha, C. M., et al. (2019) · Journal of Medicinal Food · doi:10.1089/jmf.2018.4266 · Cited by 10 · see citing works
Self-citationKim, S. R. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.153678 · Cited by 8 · see citing works
Self-citationChung, Y. C., Jeong, J. Y., & Jin, B. K. (2020) · Antioxidants · doi:10.3390/antiox9111068 · Cited by 8 · see citing works
Self-citationJeong, J. Y., Wi, R., Chung, Y. C., & Jin, B. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073486 · Cited by 8 · see citing works
Self-citationpKr-2 induces neurodegeneration via upregulation of microglial TLR4 in the hippocampus of AD brain
Kim, S., Sharma, C., Shin, M., Kim, H., Kim, J., & Kim, S. R. (2023) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2023.100593 · Cited by 5 · see citing works
Self-citationKim, S. R., & Lee, J. M. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335813 · Cited by 4 · see citing works
Self-citationKim, S. R. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.213694 · Cited by 4 · see citing works
Self-citationPark, S. M., Kim, S. S., Cho, E., Lee, G. B., Lee, J. H., Kim, D. W., Kim, J.-E., Kim, J.-E., Choi, G. E., Lee, H.-W., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03811-5 · Cited by 1 · see citing works
Self-citationVats, T., Saha, T., & Mehan, S. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00320-2
Gelen, V., Bayram, C., Kara, A., Tekiner, D., & Yeşildağ, A. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.111173
- Authors
- Kim, S. R., Chung, E. S., Bok, E., Baik, H. H., Chung, Y. C., Won, S. Y., Joe, E., Kim, T. H., Kim, S. S., Jin, M. Y., Choi, S. H., & Jin, B. K.
- Affiliations
- Ajou University (KR)
- Kyung Hee University (KR)
- Yonsei University (KR)
- Corresponding author
- Jin, Byung Kwan
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2009-12-18
- Volume
- 88
- Issue
- 7
- Pages
- 1537-1548
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W1996966804
- Cited by
- 43
- References
- 48
- Citations by year
- 2026: 3 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 3 · 2019: 3 · 2018: 3 · 2017: 3 · 2016: 3 · 2015: 6 · 2014: 4 · 2013: 1
- FWCI
- 0.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neuroscience Research (publishedVersion)
- PubMed (publishedVersion)
- AJOU Open Repository (Ajou University) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
- Keywords
- microglial activation, dopaminergic neuron death, substantia nigra, neuroinflammation, inducible nitric oxide synthase, cyclooxygenase-2, inflammatory cytokines, MAPK signaling, ERK1/2, JNK, p38 MAPK, nitric oxide synthase inhibitors, COX-2 inhibitors, neurotoxicity, mesencephalic neurons, Parkinson's disease
- MeSH terms
- Animals, Cells, Cultured, Dopamine, Female, Gliosis, Neurons, Parkinson Disease, Prothrombin, RNA, Messenger, Substantia Nigra, Rats, Sprague-Dawley, Microglia, Kringles, Inflammation Mediators, Coculture Techniques, Nitric Oxide Synthase, MAP Kinase Signaling System, CD11b Antigen, Rats, Cyclooxygenase 2, Cyclooxygenase 2 Inhibitors, Nitric Oxide Synthase Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review